Download Free Sample Report

The United States Lactose-Free Infant Formula market was valued at US$ 1.85 billion in 2024 and is projected to reach US$ 2.95 billion by 2030, at a CAGR of 8.1% during the forecast period 2024-2030.
Specially processed infant formula containing pre-digested lactose or alternative carbohydrates.
Manufacturing spans 18 specialized facilities with 94% capacity utilization. Quality control ensures zero lactose content. Distribution serves 85,000 retail points. Clinical validation supports efficacy claims. Innovation in enzyme technology improved processing by 55%. Clean label products represent 82%. Export markets expanded 48% primarily to Europe. Research partnerships with 38 nutrition institutes. Sustainability initiatives reduced packaging waste by 45%. Direct-to-consumer sales grew 135%. Organic variants increased by 62%.

This report contains market size and forecasts of Lactose-Free Infant Formula in United States, including the following market information:
•    United States Lactose-Free Infant Formula Market Revenue, 2019-2024, 2024-2030, ($ millions)
•    United States Lactose-Free Infant Formula Market Sales, 2019-2024, 2024-2030,
•    United States Top five Lactose-Free Infant Formula companies in 2023 (%)

Report Includes

This report presents an overview of United States market for Lactose-Free Infant Formula , sales, revenue and price. Analyses of the United States market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report focuses on the Lactose-Free Infant Formula sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the United States Lactose-Free Infant Formula market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues.

This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Sales Channels, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Humidifier sales, projected growth trends, production technology, sales channels and end-user industry.

Segment by Type

•    Milk Infant Formula
•    Non-milk Infant Formula

Segment by Applications

•    Premature
•    Babies with galactosemia
•    Infants with Cow's Milk Protein Allergies
•    Other

Key Companies covered in this report:

•    Similac (Abbott Laboratories)
•    Enfamil (Mead Johnson Nutrition)
•    Gerber (Nestl